Kyle Conradi

Kyle Conradi is a highly experienced Senior Clinical Research Associate with a focus on oncology and kidney disease, currently working at Proxima CRO and Reata Pharmaceuticals, Inc. since October 2022 and February 2022, respectively. With a strong adherence to protocol regulatory requirements and good clinical practice regulations, Kyle has a track record of verifying the handling and storage of clinical products under investigation. Previous roles include positions at Synteract, Parexel, and ImmunityBio, where responsibilities included clinical monitoring and compliance. Kyle also has experience as a Clinical Research Coordinator at Hill Top Research and as the Director of Business Development at Techtrials International. Kyle holds a Bachelor of Science in Biology from Florida Atlantic University and has completed coursework in Mechatronics, Robotics, and Automation Engineering at the University of North Carolina Asheville.